Sfoglia per AUTORE
BANNA G
Collezione AOU San Luigi di Orbassano

  

Items : 19

Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study. in International immunopharmacology / Int Immunopharmacol. 2022 Sep;110:108985. doi: 10.1016/j.intimp.2022.108985. Epub 2022 Jun 28.
2022
ASL Torino 4
AOU San Luigi di Orbassano

Pinato DJ; Bainbridge H; Hicks A; Chan S; Barone G; Escriu C; Signori A; McKenzie H; Addeo A; Cortellini A; Comins C; Cave J; Muthuramalingam S; Cantale O; Banna GL; Ottensmeier C; Gomes F;

International Survey on Frailty Assessment in Patients with Cancer. in The oncologist / Oncologist. 2022 Oct 1;27(10):e796-e803. doi: 10.1093/oncolo/oyac133.
2022
ASL Torino 4
AOU San Luigi di Orbassano

Garetto L; Maltese G; O'Carroll E; Musolino N; Bambury K; Battisti NML; Haydock MM; Cantale O; Banna GL; Addeo A; Gomes F;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.
2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Russano M; Porzio G; Tiseo M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Metro G; Spinelli GP; Passiglia F; Migliorino MR; Ricciardi S; Pecci F; Zoratto F; De Tursi M; Di Marino P; Mansueto G; Tuzi A; Gori S; Della Gravara L; Rastelli F; Chiari R; Macerelli M; Marchetti P; Gelibter A; Antonuzzo L; Berardi R; et alii...

Molecular Characterization of Prostate Cancers in the Precision Medicine Era. in Cancers / Cancers (Basel). 2021 Sep 24;13(19):4771. doi: 10.3390/cancers13194771.
2021
AOU San Luigi di Orbassano

Giunta EF; Annaratone L; Bollito E; Porpiglia F; Cereda M; Banna GL; Mosca A; Marchiò C; Rescigno P;

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.
2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU Novara

Russo A; Adamo V; Metro G; De Filippis M; Simona C; Natalizio S; Migliorino MR; Ricciardi S; Landi L; Minuti G; Buti S; Nigro O; Cantini L; Russano M; Citarella F; Bracarda S; Filetti M; Zoratto F; Mansueto G; De Tursi M; Gori S; Rocco D; Chiari R; Rastelli F; Gelibter A; Targato G; Signorelli D; De Toma A; Mazzoni F; et alii...

Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study. in Thoracic cancer / Thorac Cancer. 2021 Mar;12(6):880-889. doi: 10.1111/1759-7714.13852. Epub 2021 Feb 1.
2021
AOU San Luigi di Orbassano

Donisi C; De Toma A; Landi L; Minuti G; Bordi P; Leonetti A; Nigro O; Cantini L; Russano M; Pensieri MV; Montrone M; Citarella F; Filetti M; Mansueto G; Zoratto F; Di Marino P; De Tursi M; Inno A; Gravara LD; Chiari R; Rastelli F; Follador A; Occhipinti MA; Gelibter A; Signorelli D; Di Noia V; Antonuzzo L; Rossi G; Sforza V; et alii...

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cannita K; Porzio G; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Russo A; Adamo V; Metro G; Olmetto E; Tabbò F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Tuzi A; Bisonni R; Follador A; Siringo M; Gelibter A; Signorelli D; De Toma A; Garassino MC; Mazzoni F; Russano M; Citarella F; Filetti M; Zoratto F; Mansueto G; et alii...

2021
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Bordi P; Tuzi A; Cantini L; Russano M; Citarella F; Santini D; Filetti M; Zoratto F; Mansueto G; Di Marino P; Grassadonia A; Michele T; Inno A; Della Gravara L; Rocco D; Chiari R; Rastelli F; Macerelli M; Marchetti P; Siringo M; et alii...

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study). in Clinical Medicine Insights. Oncology / Clin Med Insights Oncol. 2021 Jul 8;15:11795549211021667. doi: 10.1177/11795549211021667. eCollectio
2021
AOU San Luigi di Orbassano

Bersanelli M; Buti S; Cortellini A; Bandini M; Banna GL; Pederzoli F; Farè E; Raggi D; Giannatempo P; De Giorgi U; Basso U; Losanno T; Santini D; Mucciarini C; Tucci M; Tambaro R; Farnesi A; Caffo O; Veccia A; Naglieri E; Briganti A; Procopio G; Pignata S; Necchi A;

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ? 50%: a multicenter study with external validation. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001403. doi: 10.1136/jitc-2020-001403.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Giusti R; Porzio G; Ficorella C; Petrelli F; Addeo A; De Toma A; Friedlaender A; Tabbò F; Ricciardi S; Della Gravara L; Guaitoli G; Landi L; Scodes S; Buti S; Nigro O; Ferrara MG; Targato G; Cantini L; Russano M; Citarella F; Pizzutilo P; Filetti M; Grossi F; Zoratto F; Mansueto G; De Tursi M; Di Marino P; Rocco D; Inno A; et alii...

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ? 50% and Their Relationship With Clinical Outcomes. in Clinical lung cancer / Clin Lung Cancer. 2020 Nov;21(6):498-508.e2. doi: 10.1016/j.cllc.2020.06.010. Epub 2020 Jun 21.
2020
AOU San Luigi di Orbassano

Belderbos RA; De Filippis M; Dal Bello MG; Della Gravara L; Bertolini F; Baldessari C; Guaitoli G; Landi L; Antonuzzo L; Scodes S; Pettoruti L; Leonetti A; D'Argento E; Ferrara MG; Nigro O; Sforza V; Follador A; Torniai M; Cantini L; Russano M; Citarella F; Occhipinti MA; Sala L; Pizzutilo P; Catino A; Filetti M; Ghidini M; Tudini M; Santoni M; et alii...

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ??50. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2020 Nov;69(11):2209-2221. doi: 10.1007/s00262-020-02613-9. Epub 2020 May
2020
AOU San Luigi di Orbassano

Dal Bello MG; Della Gravara L; Baldessari C; Guaitoli G; Landi L; Scodes S; Antonuzzo L; Bordi P; Buti S; D'Argento E; Ferrara MG; Sforza V; Nigro O; Targato G; Cantini L; Torniai M; Marco R; Citarella F; Sala L; Pizzutilo P; Catino A; Filetti M; Rijavec E; Tudini M; Santoni M; Zoratto F; Mansueto G; De Tursi M; Gori S; et alii...

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Città di Torino

Banna GL; Camisa R; Di Maio M; Rossi G; Rossi A; Cortinovis DL; Bria E; Novello S; Baldessari C; Bartoli G; Pizzutilo EG; Landi L; Toschi L; Dall'Olio FG; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Camerini A; Bearz A; Sala E; Cerea G; Migliorino MR; Bennati C; Ardizzoni A; Vita E; Rossi S; et alii...

Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era. in Current oncology reports / Curr Oncol Rep. 2019 Nov 25;21(12):107. doi: 10.1007/s11912-019-0852-9.
2019
AOU San Luigi di Orbassano

Addeo A; Buffoni L; Banna GL; Friedlaender A;

Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach. in PloS one / PLoS One. 2019 Nov 13;14(11):e0224027. doi: 10.1371/journal.pone.0224027. eCollection 2019.
2019
AOU San Luigi di Orbassano

Taraborrelli M; Paci M; Tiseo M; Botti A; Bria E; Baldini E; Vagge S; Banna G; Perna M; Capelletto E; Franceschini D; Borghetti P; Greco C; Greco S; Grossi F; Bonti V; Ferrari K; Maragna V; Ciammella P; Giaj-Levra N; Bruni A; Poletti V; Granone P; Ricardi U; Novello S; Scotti V;

2019
AOU San Luigi di Orbassano

Bandini M; Farè E; Raggi D; De Giorgi U; Banna GL; Basso U; Losanno T; Bersanelli M; Buti S; Santini D; Mucciarini C; Tucci M; Tambaro R; Farnesi A; Ficorella C; Caffo O; Naglieri E; Pederzoli F; Pignata S; Necchi A;

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 May;95:73-81. doi: 10.1016/j.lungcan.2016.02.011. Epub 2016 Feb 26.
2016
AOU San Luigi di Orbassano
AOU Alessandria

Rossi A; Spitaleri G; Bria E; Cecere F; Rijavec E; Rizzo E; Barbieri F; Menis J; Filipazzi V; Mucciarini C; Genestreti G; Bearz A; Barzelloni ML; Ardizzoia A; Banna GL; Casartelli C; Zilembo N; Cortinovis D; Piovano PL; Caffo O; Novello S; Martelli O; Di Maio M; Morabito A; Vavalà T; Follador A; Tiseo M; Galetta D;

2013
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Mirabelli D; Novello S; Ardissone F; Casadio C; Botta M; Piccolini E; Pazé E; Alabiso O; Brentisci C; Gangemi M; Stura A; Biava A; Ruffini E; Guerrera F; Filosso PL; Cappuzzo F; Tiseo M; Chiari R; Landi L; Ricciardi S; Rossi E; Galetta D; Milella M; D'Incecco A; Haspinger ER; Cortinovis D; Santo A; Banna G; Facchinetti F; et alii...

Maintenance therapy in NSCLC: why? To whom? Which agent? in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2011 May 6;30(1):50. doi: 10.1186/1756-9966-30-50.
2011
AOU San Luigi di Orbassano

Novello S; Milella M; Tiseo M; Banna G; Cortinovis D; Di Maio M; Garassino M; Maione P; Martelli O; Vavalà T; Bria E;